3PBiopharmaceuticals offers experience in CELL FREE technology
The experience acquired with one of its clients allows 3P the capability to offer this alternative technology in its services pipeline.
The Upstream and the Technical Services teams have headed a cell free process; this is a state of the art technology that allows obtaining a specific enzyme in a non-stop fermentation process. This is possible thanks to an enzymatic biochemical reaction without any cellular mechanism interaction.
This is an important landmark for the company in several aspects:
- The successful coverage of a continuous production processes.
- Control of temperature during all stages to ensure stability throughout the process with adaptation of equipments and facilities to guarantee this condition
- The scaling-up of this technology with the singularity of maintaining constantly the temperature to guarantee the reproducibility of the process.
- The development of this alternative technology opens the door to those potential clients who need this type of resources to produce proteins and small molecules and sets the company in a leading position in the global biotechnology industry.
About 3PBiopharmaceuticals.
3P is a CDMO organization that develops and manufactures biological and cellular therapy products for preclinical, clinical trials and commercial phases for other companies under GMP conditions.
Contact Information:
Edurne Gil
3P Biopharmaceuticals Communications Manager
Tel.: + 34 984 346480
eMail: egil[at]3pbio.com
Web: www.3pbio.com
Biocytogen Co Ltd
Draupnir Bio ApS